Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 

  FDsys > More Information
(Search string is required)
 

16-2826 - Smith v. Teva Pharmaceuticals USA, Inc et al


Download Files

Metadata

Document in Context
16-2826 - Smith v. Teva Pharmaceuticals USA, Inc et al
March 20, 2017
PDF | More
ORDER TO SHOW CAUSE - On or before April 6, 2017, Plaintiff shall show good cause, in writing, as to why this case should not be dismissed for frivolity or for failure to state a claim. Show Cause Response due by 4/6/2017. Plaintiff's 31 Motion for Leave to Proceed In Forma Pauperis (ECF 31) is granted; Plaintiff's other motions to proceed in forma pauperis (ECF 22, 28) are moot. Signed by Magistrate Judge Gerald L. Rushfelt on 3/20/17. Mailed to pro se party Bernard L. Smith by regular and certified mail ; Certified Tracking Number: 7012 3460 0000 8262 5910.(kao) Modified on 6/12/2017 WO(lak).
April 7, 2017
PDF | More
MEMORANDUM AND ORDER OF DISMISSAL - See Order for details. Signed by District Judge Julie A. Robinson on 4/7/17. Mailed to pro se party Bernard L. Smith by regular and certified mail. (7012 3460 0000 8262 6009) (kao) Modified on 4/10/2017 to correct Judge name. (kao)